Filing Details
- Accession Number:
- 0000880771-11-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-24 11:42:40
- Reporting Period:
- 2011-05-20
- Filing Date:
- 2011-05-24
- Accepted Time:
- 2011-05-24 11:42:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1328576 | D Ira Lawrence | 950 Tower Lane, Suite 900 Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-20 | 30,000 | $1.75 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-20 | 30,000 | $5.77 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-05-23 | 30,000 | $2.23 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-23 | 30,000 | $5.77 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-05-20 | 30,000 | $5.77 | 30,000 | $1.75 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-05-23 | 30,000 | $5.77 | 30,000 | $2.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-06-10 | No | 4 | M | Direct | |
| 0 | 2019-06-09 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.76 to $5.7947.
- The price reported in Column 4 is a weighted average price. These share were sold in multiple transactions at prices ranging from $5.74 to$5.79
- Granted under the Issuer's 2004 Outside Directors Stock Option Plan.
- Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer.
Billionaire Hedge Funds
